This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Keio University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hironobu Okuno: Innovator in Therapeutic Applications
Introduction
Hironobu Okuno is a notable inventor based in Tokyo, Japan. He is affiliated with Keio University, where he contributes to research and innovation in the field of therapeutic agents. Although he currently holds no granted patents, his work is significant in the realm of medical advancements.
Latest Patent Applications
Hironobu Okuno's latest patent application is titled "Therapeutic Agent for Amyotrophic Lateral Sclerosis and Composition for Treatment." This application describes a therapeutic agent for amyotrophic lateral sclerosis that includes a compound represented by Formula (1). In this formula, Reach independently represents an alkyl group having 1 to 6 carbon atoms or a 4-hydroxyphenethyl group, and n represents an integer of 1 to 3. This innovative approach aims to provide effective treatment options for individuals suffering from this debilitating condition.
Conclusion
Hironobu Okuno's contributions to the field of therapeutic agents highlight his commitment to advancing medical science. His ongoing research at Keio University is poised to make a significant impact on the treatment of amyotrophic lateral sclerosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile